Cover Image

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Show other versions (1)

Background: Liver Transplantation (LT) is treatment of choice for patients with hepatocellular carcinoma (HCC) within MILAN Criteria. Tumour progression and subsequent dropout from waiting list have significant impact on the survival. Transarterial chemoembolization (TACE) controls tumour growth in...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoffmann, Katrin (Author) , Ganten, Tom M. (Author) , Gotthardt, Daniel (Author) , Radeleff, Boris (Author) , Karapanagiotou-Schenkel, Irini (Author) , Kalle, Christof von (Author) , Jäger, Dirk (Author) , Büchler, Markus W. (Author) , Schemmer, Peter (Author)
Format: Article (Journal)
Language:English
Published: 2015 May 11
In: BMC cancer
Year: 2015, Volume: 15
ISSN:1471-2407
DOI:10.1186/s12885-015-1373-z
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12885-015-1373-z
Verlag, kostenfrei, Volltext: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449604/
Get full text
Author Notes:Katrin Hoffmann, Tom Ganten, Daniel Gotthardtp, Boris Radeleff, Utz Settmacher, Otto Kollmar, Silvio Nadalin, Irini Karapanagiotou-Schenkel, Christof von Kalle, Dirk Jäger, Markus W Büchler and Peter Schemmer
Search Result 1
Cover Image

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial by Hoffmann, Katrin (Author) , Ganten, Tom M. (Author) , Gotthardt, Daniel (Author) , Radeleff, Boris (Author) , Karapanagiotou-Schenkel, Irini (Author) , Kalle, Christof von (Author) , Jäger, Dirk (Author) , Büchler, Markus W. (Author) , Schemmer, Peter (Author) ,

BioMed Central 2016

Get full text
Article (Journal) Book/Monograph Online Resource

Saved in:
Show all versions (2)

Similar Items